Lipocine Inc.LPCNNASDAQ
Loading
Year-over-year total asset growth rate
5Y CAGR
+19.0%/yr
Long-term compound
Percentile
P77
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 5.80% |
| Q3 2025 | -13.48% |
| Q2 2025 | -9.38% |
| Q1 2025 | -8.93% |
| Q4 2024 | 8.76% |
| Q3 2024 | -10.13% |
| Q2 2024 | -9.49% |
| Q1 2024 | 10.63% |
| Q4 2023 | -7.08% |
| Q3 2023 | -18.80% |
| Q2 2023 | -10.40% |
| Q1 2023 | -9.38% |
| Q4 2022 | -4.77% |
| Q3 2022 | -6.56% |
| Q2 2022 | -11.37% |
| Q1 2022 | -9.30% |
| Q4 2021 | 29.94% |
| Q3 2021 | -14.39% |
| Q2 2021 | -6.72% |
| Q1 2021 | 99.49% |
| Q4 2020 | 2.43% |
| Q3 2020 | 5.39% |
| Q2 2020 | 11.88% |
| Q1 2020 | 6.78% |
| Q4 2019 | 13.36% |
| Q3 2019 | -11.87% |
| Q2 2019 | -14.41% |
| Q1 2019 | 10.25% |
| Q4 2018 | -8.08% |
| Q3 2018 | -10.34% |
| Q2 2018 | -20.13% |
| Q1 2018 | 25.10% |
| Q4 2017 | -3.54% |
| Q3 2017 | -6.39% |
| Q2 2017 | 3.03% |
| Q1 2017 | -0.44% |
| Q4 2016 | -7.48% |
| Q3 2016 | -11.38% |
| Q2 2016 | -13.99% |
| Q1 2016 | -14.55% |